Literature DB >> 36266326

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.

Amer M Zeidan1, Jan Philipp Bewersdorf2, Rena Buckstein3, Mikkael A Sekeres4, David P Steensma5, Uwe Platzbecker6, Sanam Loghavi7, Jacqueline Boultwood8, Rafael Bejar9, John M Bennett10, Uma Borate11, Andrew M Brunner12, Hetty Carraway13, Jane E Churpek14, Naval G Daver15, Matteo Della Porta16, Amy E DeZern17, Fabio Efficace18, Pierre Fenaux19, Maria E Figueroa4, Peter Greenberg20, Elizabeth A Griffiths21, Stephanie Halene22, Robert P Hasserjian23, Christopher S Hourigan24, Nina Kim25, Tae Kon Kim26, Rami S Komrokji27, Vijay Kutchroo28, Alan F List27, Richard F Little29, Ravi Majeti30, Aziz Nazha31, Stephen D Nimer4, Olatoyosi Odenike32, Eric Padron27, Mrinal M Patnaik33, Gail J Roboz34, David A Sallman27, Guillermo Sanz35, Maximilian Stahl36, Daniel T Starczynowski37, Justin Taylor4, Zhuoer Xie27, Mina Xu38, Michael R Savona26, Andrew H Wei39, Omar Abdel-Wahab2, Valeria Santini40.   

Abstract

Entities:  

Year:  2022        PMID: 36266326     DOI: 10.1038/s41375-022-01724-9

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   12.883


× No keyword cloud information.
  43 in total

1.  Clinical significance of somatic mutation in unexplained blood cytopenia.

Authors:  Luca Malcovati; Anna Gallì; Erica Travaglino; Ilaria Ambaglio; Ettore Rizzo; Elisabetta Molteni; Chiara Elena; Virginia Valeria Ferretti; Silvia Catricalà; Elisa Bono; Gabriele Todisco; Antonio Bianchessi; Elisa Rumi; Silvia Zibellini; Daniela Pietra; Emanuela Boveri; Clara Camaschella; Daniela Toniolo; Elli Papaemmanuil; Seishi Ogawa; Mario Cazzola
Journal:  Blood       Date:  2017-04-19       Impact factor: 22.113

2.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

Review 3.  Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges.

Authors:  Rory M Shallis; Rong Wang; Amy Davidoff; Xiaomei Ma; Amer M Zeidan
Journal:  Blood Rev       Date:  2019-04-29       Impact factor: 8.250

Review 4.  Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it.

Authors:  Amer M Zeidan; Rory M Shallis; Rong Wang; Amy Davidoff; Xiaomei Ma
Journal:  Blood Rev       Date:  2018-09-21       Impact factor: 8.250

5.  Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia.

Authors:  Xueyan Chen; Megan Othus; Brent L Wood; Roland B Walter; Pamela S Becker; Mary-Elizabeth Percival; Janis L Abkowitz; Frederick R Appelbaum; Elihu H Estey
Journal:  Leuk Lymphoma       Date:  2020-12-19

6.  International scoring system for evaluating prognosis in myelodysplastic syndromes.

Authors:  P Greenberg; C Cox; M M LeBeau; P Fenaux; P Morel; G Sanz; M Sanz; T Vallespi; T Hamblin; D Oscier; K Ohyashiki; K Toyama; C Aul; G Mufti; J Bennett
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

Review 7.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Authors:  Joseph D Khoury; Eric Solary; Oussama Abla; Yassmine Akkari; Rita Alaggio; Jane F Apperley; Rafael Bejar; Emilio Berti; Lambert Busque; John K C Chan; Weina Chen; Xueyan Chen; Wee-Joo Chng; John K Choi; Isabel Colmenero; Sarah E Coupland; Nicholas C P Cross; Daphne De Jong; M Tarek Elghetany; Emiko Takahashi; Jean-Francois Emile; Judith Ferry; Linda Fogelstrand; Michaela Fontenay; Ulrich Germing; Sumeet Gujral; Torsten Haferlach; Claire Harrison; Jennelle C Hodge; Shimin Hu; Joop H Jansen; Rashmi Kanagal-Shamanna; Hagop M Kantarjian; Christian P Kratz; Xiao-Qiu Li; Megan S Lim; Keith Loeb; Sanam Loghavi; Andrea Marcogliese; Soheil Meshinchi; Phillip Michaels; Kikkeri N Naresh; Yasodha Natkunam; Reza Nejati; German Ott; Eric Padron; Keyur P Patel; Nikhil Patkar; Jennifer Picarsic; Uwe Platzbecker; Irene Roberts; Anna Schuh; William Sewell; Reiner Siebert; Prashant Tembhare; Jeffrey Tyner; Srdan Verstovsek; Wei Wang; Brent Wood; Wenbin Xiao; Cecilia Yeung; Andreas Hochhaus
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

Review 8.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

9.  Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.

Authors:  Elsa Bernard; Yasuhito Nannya; Robert P Hasserjian; Sean M Devlin; Heinz Tuechler; Juan S Medina-Martinez; Tetsuichi Yoshizato; Yusuke Shiozawa; Ryunosuke Saiki; Luca Malcovati; Max F Levine; Juan E Arango; Yangyu Zhou; Francesc Solé; Catherine A Cargo; Detlef Haase; Maria Creignou; Ulrich Germing; Yanming Zhang; Gunes Gundem; Araxe Sarian; Arjan A van de Loosdrecht; Martin Jädersten; Magnus Tobiasson; Olivier Kosmider; Matilde Y Follo; Felicitas Thol; Ronald F Pinheiro; Valeria Santini; Ioannis Kotsianidis; Jacqueline Boultwood; Fabio P S Santos; Julie Schanz; Senji Kasahara; Takayuki Ishikawa; Hisashi Tsurumi; Akifumi Takaori-Kondo; Toru Kiguchi; Chantana Polprasert; John M Bennett; Virginia M Klimek; Michael R Savona; Monika Belickova; Christina Ganster; Laura Palomo; Guillermo Sanz; Lionel Ades; Matteo Giovanni Della Porta; Harold K Elias; Alexandra G Smith; Yesenia Werner; Minal Patel; Agnès Viale; Katelynd Vanness; Donna S Neuberg; Kristen E Stevenson; Kamal Menghrajani; Kelly L Bolton; Pierre Fenaux; Andrea Pellagatti; Uwe Platzbecker; Michael Heuser; Peter Valent; Shigeru Chiba; Yasushi Miyazaki; Carlo Finelli; Maria Teresa Voso; Lee-Yung Shih; Michaela Fontenay; Joop H Jansen; José Cervera; Yoshiko Atsuta; Norbert Gattermann; Benjamin L Ebert; Rafael Bejar; Peter L Greenberg; Mario Cazzola; Eva Hellström-Lindberg; Seishi Ogawa; Elli Papaemmanuil
Journal:  Nat Med       Date:  2020-08-03       Impact factor: 53.440

10.  Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal.

Authors:  Elihu Estey; Robert P Hasserjian; Hartmut Döhner
Journal:  Blood       Date:  2022-01-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.